GENEVA, Sept. 7 -- HELMHOLTZ-ZENTRUM FÜR INFEKTIONSFORSCHUNG GMBH filed a patent application (EP2026/055167) for “NOVEL DNAN-TARGETING, ANTI-TUBERCULAR MYCOPLANECIN DERIVATIVES”. With publication no. WO/2026/180541, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 11/02

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....